Senti Biosciences

Senti Biosciences EBITDA per Share

The EBITDA per Share of Senti Biosciences (SNTI) as of Oct 19, 2026 is -2.83 USD. In the previous year, EBITDA per Share was -12.66 USD — a change of -77.61% (higher).

EBITDA per Share

-2.83USD

YoY

-77.61%

Last updated:

EBITDA per Share of Senti Biosciences is 2025 -2.83 USD. EBITDA per Share of Senti Biosciences was 2024 -12.66 USD. It decreases by -77.61% higher compared to the previous year.

The Senti Biosciences EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-0.70 USD
Jan 1, 2020
-1.72 USD
Jan 1, 2021
-9.26 USD
Jan 1, 2022
-16.12 USD
Jan 1, 2023
-20.59 USD
Jan 1, 2024
-12.66 USD
Jan 1, 2025
-2.83 USD
The Senti Biosciences EBITDA per Share history
YEAREBITDA per ShareYoY
-2.83USD-77.61%
-12.66USD-38.51%
-20.59USD+27.74%
-16.12USD+73.96%
-9.26USD+438.78%
-1.72USD+145.87%
-0.70USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Senti Biosciences Stock analysis

What does Senti Biosciences do? Senti Biosciences Inc is a biotechnology company headquartered in South San Francisco, California. The company has 122 employees and went public on May 26, 2021. It develops cell and gene therapies using its gene circuit platform technology. The company's product candidates include SENTI-202, a Logic Gated (OR + NOT) off-the-shelf CAR-NK cell therapy for cancer treatment, SENTI-401 for colorectal cancer and other solid tumors, and SENTI-301A for hepatocellular carcinoma and other solid tumors. Its platform is designed for application across multiple cell types and therapeutic modalities. Senti Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Senti Biosciences stock

EBITDA per Share of Senti Biosciences is -2.83 USD in 2025.

EBITDA per Share of Senti Biosciences changed from -12.66 USD to -2.83 USD, representing a -77.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Senti Biosciences since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Senti Biosciences

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Senti Biosciences